Literature DB >> 14749043

A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.

Mats Stridsberg1, Barbro Eriksson, Kjell Oberg, Eva Tiensuu Janson.   

Abstract

INTRODUCTION: The primary structure of human chromogranin A (CgA) not only contains 10 pairs of basic amino acids, which are potential cleavage sites for specific endogenous proteases, but also other sites in the molecule can be subjected to cleavage. Several CgA-related peptides have been identified in tissue, and many of the biological effects attributed to CgA seem to be mediated by these peptides.
MATERIALS AND METHODS: Peptides homologous to defined parts of the human CgA molecule were selected and synthesised. Antibodies were raised, and 11 specific radioimmunoassays were developed. Plasma samples from 20 patients with neuroendocrine tumours were collected and measured in all assays.
RESULTS: All assays measured circulating levels of CgA-derived peptides. Only four of the assays measured concentrations that correlated with that of total CgA. However, concentrations of the individual CgA-related peptides were generally lower than the concentration of total CgA. Different neuroendocrine tumours seem to process CgA differently. The ratio between a given region-specific assay and total CgA is inversely correlated to tumour activity.
CONCLUSION: The assays presented allow measurements of defined regions of CgA and will thus become important tools for further studies of processing of CgA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749043     DOI: 10.1016/j.regpep.2003.10.023

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  17 in total

Review 1.  Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.

Authors:  Guida M Portela-Gomes; Lars Grimelius; Mats Stridsberg
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

2.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

3.  Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.

Authors:  Andreas Tartaglia; Guida M Portela-Gomes; Kjell Oberg; Paolo Vezzadini; Maria P Foschini; Mats Stridsberg
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

4.  Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses.

Authors:  Sucheta M Vaingankar; Ying Li; Nilima Biswas; Jiaur Gayen; Sonia Choksi; Fangwen Rao; Michael G Ziegler; Sushil K Mahata; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

5.  Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure.

Authors:  Daniel T O'Connor; Gu Zhu; Fangwen Rao; Laurent Taupenot; Maple M Fung; Madhusudan Das; Sushil K Mahata; Manjula Mahata; Lei Wang; Kuixing Zhang; Tiffany A Greenwood; Pei-an Betty Shih; Myles G Cockburn; Michael G Ziegler; Mats Stridsberg; Nicholas G Martin; John B Whitfield
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

6.  Immunohistochemical staining of human islet cells with region-specific antibodies against secretogranins II and III.

Authors:  M Stridsberg; L Grimelius; G M Portela-Gomes
Journal:  J Anat       Date:  2008-01-25       Impact factor: 2.610

Review 7.  Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.

Authors:  Angelo Corti; Fabrizio Marcucci; Tiziana Bachetti
Journal:  Pflugers Arch       Date:  2017-10-10       Impact factor: 3.657

8.  Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Authors:  Yuqing Chen; Manjula Mahata; Fangwen Rao; Srikrishna Khandrika; Maite Courel; Maple M Fung; Kuixing Zhang; Mats Stridsberg; Michael G Ziegler; Bruce A Hamilton; Michael S Lipkowitz; Laurent Taupenot; Caroline Nievergelt; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2009-06-11       Impact factor: 10.121

9.  MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension.

Authors:  Ryan S Friese; Angelina E Altshuler; Kuixing Zhang; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Martin L Jirout; Rany M Salem; Jiaur R Gayen; Nitish R Mahapatra; Nilima Biswas; Mo Cale; Sucheta M Vaingankar; Hyung-Suk Kim; Maïté Courel; Laurent Taupenot; Michael G Ziegler; Nicholas J Schork; Michal Pravenec; Sushil K Mahata; Geert W Schmid-Schönbein; Daniel T O'Connor
Journal:  Hum Mol Genet       Date:  2013-05-13       Impact factor: 6.150

10.  Chromogranin A and cortisol at intraoperative repeated noxious stimuli: Surgical stress in a dog model.

Authors:  Odd Viking Höglund; Ragnvi Hagman; Mats Stridsberg
Journal:  SAGE Open Med       Date:  2015-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.